Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
High-dose Bevacizumab in Advanced Renal Carcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib and Bevacizumab for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)
- Status
- TERMINATED
- Phase
- PHASE2